Mursla
Tissue-specific extracellular vesicle tests and analytics for cancer surveillance and precision medicine
Highlights
- New on EvolcAdded 2026-11-14
About Mursla
Mursla Bio develops blood-based tests and a tissue-specific extracellular vesicle platform for precision medicine. Its EvoLiver test is designed to support liver cancer surveillance in people with cirrhosis, while the platform profiles vesicle proteins and RNA for biomarker discovery and patient stratification.
The company also works with pharmaceutical partners on precision medicine programmes, including in MASH. Mursla Limited was founded in 2017 and is based in Cambridge, United Kingdom; EvoLiver received FDA Breakthrough Device Designation in April 2025.
Product: Blood-based EvoLiver liver cancer surveillance test and a tissue-specific extracellular vesicle platform for multiomic profiling.
Jobs at Mursla
Leadership
- Pierre Arsène · Founder & CEOSource: company website
- Karin Schmitt · Chief operating officerSource: company website
More biotech & pharma companies
Myricx Pharma
Develops antibody-drug conjugate cancer therapies using payloads based on N-myristoyltransferase inhibitorsN2SA
Pharmaceutical licensing and distribution for healthcare providers, distributors and public-sector partners across Southern AfricaNew on EvolcNanomerics
Develops polymer-based drug and gene delivery technologies for pharmaceutical therapies in ophthalmology and CNS conditionsNew on EvolcNanosyrinx
Develops targeted intracellular delivery of protein therapeutics for biotech and pharmaceutical drug developersNew on EvolcNanovery
DNA nanorobot assays for biotech and life sciences researchers quantifying RNA therapeutics and nucleic acid biomarkersNew on EvolcNars UK Consulting
Pharmaceutical ingredient, finished-dose medicine and PPE supply, plus know-how consulting for businesses and healthcare buyersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.